Flag of the European Union EU Clinical Trials Register Help

Clinical trials for czech republic

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    5,164 result(s) found for: czech republic. Displaying page 1 of 259.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2008-007067-16 Sponsor Protocol Number: TERJ001 Start Date*: 2009-02-11
    Sponsor Name:JELFA SA
    Full Title: Randomised, double-blind, parallel-group, comparative study of two terbinafine products
    Medical condition: tinea pedis (interdigital, Athlet´s foot)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-000607-42 Sponsor Protocol Number: KN-1/06 Start Date*: 2006-02-20
    Sponsor Name:Institute for clinical and experimental Medicine
    Full Title: Treatment of borderline changesin protocol biopsy 3 months after renal transplantation
    Medical condition: Patients with transplanted kidney and stabilised graft function
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-001825-28 Sponsor Protocol Number: T2DM-CLI-2012 Start Date*: 2012-08-20
    Sponsor Name:Fakultní nemocnice Ostrava,Czech Republic
    Full Title: Randomised clinical study of autologous bone marrow aspirate concentrate (BMAC) activity fo No_option_critical limb ischemia in Type-II diabetes mellitus (DILAEG)
    Medical condition: No-option critical limb ischemia patients with T2DM and foot ulcers
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-000122-31 Sponsor Protocol Number: Lantu_L_00722 Start Date*: 2006-03-09
    Sponsor Name:Aventis Pharma s.r.o.
    Full Title: Srovnání fluktuací glykemií při bazální substituci humánním inzulínem NPH a inzulínovým analogem glargine (kontinuální měření glykemií)
    Medical condition: Type 1 and 2 diabetes mellitus
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2004-001405-10 Sponsor Protocol Number: 01/2002 Start Date*: 2004-09-07
    Sponsor Name:Lybar a.s.
    Full Title: Randomized,double-blind, placebo- controlled trial Phase III to discover efficacy and safety of Diffusil H Forte spray containing carbaryl in patients with pediculosis
    Medical condition: Randomizovaná,dvojitě zaslepená,placebem kontrolovaná klinická studie fáze III s cílem prokázat účinnost a bezpečnost podání přípravku Diffusil H Forte u pacientů s prokázaným nálezem pedikulózou v...
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-004127-36 Sponsor Protocol Number: expir1 Start Date*: 2013-12-19
    Sponsor Name:Podřipská nemocnice s poliklinikou, Roudnice n.L., s.r.o
    Full Title: Offline monitoring of parallel concentrations of intravenously administered anesthetics, opiates and relaxants in breath and in blood during anesthesia - a pilot study
    Medical condition: intravenous anaesthesia
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2005-002342-19 Sponsor Protocol Number: 07/05/ALE/TP4 Start Date*: 2005-07-07
    Sponsor Name:Zentiva, a.s.
    Full Title: A multicentre, open label study to evaluate the safety and efficacy of Alendros 70 therapy administered 70mg once a week in women with postmenopausal osteoporosis
    Medical condition: postmenopausal osteoporosis
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2009-017295-24 Sponsor Protocol Number: 997262001 Start Date*: 2010-03-10
    Sponsor Name:University Hospital Motol
    Full Title: Phase I/II clinical trial:Immunotherapy of hormone-refractory prostate cancer patients with dendritic cell-based vaccine (Fáze I/II klinické studie imunoterapie hormonálně refrakterního karcinomu p...
    Medical condition: Patients with hormone-refractory prostate cancer
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: CZ (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-017259-91 Sponsor Protocol Number: 997262002 Start Date*: 2010-03-10
    Sponsor Name:University Hospital Motol
    Full Title: Phase I/II clinical trial: Immunotherapy of prostate cancer patients in biochemical relapse with dendritic cell-based vaccine
    Medical condition: Patients with prostate cancer in the stage of biochemical relapse
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: CZ (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-002686-36 Sponsor Protocol Number: 20053 Start Date*: 2005-09-19
    Sponsor Name:Všeobecná fakultní nemocnice v Praze
    Full Title: Developmental pharmacokinetics and pharmacogenetics aspects of analgosedation by tramadol of newborns, infants and older children treated at the intensive care unit
    Medical condition: children requiring analgosedation with tramadol
    Disease:
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002276-42 Sponsor Protocol Number: 61/O4/OX/Rh Start Date*: 2004-12-13
    Sponsor Name:IVAX Pharmaceuticals s.r.o.
    Full Title: Tolerability and safety of Oxamet® in patients with acute rhinitis
    Medical condition: Acute rhinitis.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-003350-99 Sponsor Protocol Number: Ringerfundin-01/2005 Start Date*: 2005-08-26
    Sponsor Name:B. Braun Medical s.r.o.
    Full Title: METABOLIC EFFECT OF RINGERFUNCIN B. BRAUN IN HEALTHY VOLUNTEERS AND COMPARISON WITH IONIC SOLUTION PLASMA-LYTE BAXTER
    Medical condition: healthy voluntaries
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002893-76 Sponsor Protocol Number: PRAGUE-10 Start Date*: 2008-02-13
    Sponsor Name:Charles University in Prague, Third Faculty of Medicine
    Full Title: MEtabolic Therapy with Trimetazidine in Acute heart failure: an open pilot randomized trial (The METTA – PRAGUE 10 Trial)
    Medical condition: Acute Heart Failure
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-015955-25 Sponsor Protocol Number: 1/09 Start Date*: 2010-02-01
    Sponsor Name:University Hospital
    Full Title: INDIVIDUAL 5-FLUOROURACIL DOSE INDIVIDUALIZATION IN PATIENTS WITH COLORECTAL CANCER
    Medical condition: colorectal cancer
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2005-002873-62 Sponsor Protocol Number: 2005-34-IMP-2 Start Date*: 2006-02-15
    Sponsor Name:HEXAL AG
    Full Title: RANDOMIZED, OPEN LABEL, MULTICENTER, PHASE II STUDY ON PHARMACOKINETICS, PHARMACODYNAMICS, EFFICACY AND SAFETY OF BUSERELIN 3M IMPLANT HEXAL IN PATIENTS WITH ADVANCED PROSTATIC CANCER IN COMPARISON...
    Medical condition: Palliative treatment of advanced prostatic cancer
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2008-003008-72 Sponsor Protocol Number: V87P12 Start Date*: 2008-11-06
    Sponsor Name:Novartis Vaccines and Diagnostics S.r.l
    Full Title: A Phase III, Randomized, Open-label, Single-center Study to Evaluate the Safety and Immunogenicity of a FLUAD-H5N1 Influenza Vaccine in Adult Subjects Using Four Different Vaccination Schedules
    Medical condition: Pandemic influenza
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2004-001239-42 Sponsor Protocol Number: RE&D VÚFB 8/2004/Tol-4 Start Date*: 2005-07-27
    Sponsor Name:RE&D VÚFB, s.r.o.
    Full Title: Evaluation of tolerance of preparation KETOPROFEN HBF GEL 2.5% (Herbacos-bofarma) and its comparison with preparation PROFENID GEL (Laboratoires Aventis) in patients with benign joint injury.
    Medical condition: treatment of bruised or sprained joints
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-000940-10 Sponsor Protocol Number: RE&D VÚFB/8/2005/Tol-5 Start Date*: 2005-07-04
    Sponsor Name:RE&D VÚFB, s.r.o.
    Full Title: Evaluation of tolerance and efficacy of preparation TERBINAFIN HBF CREAM (Herbacos-Bofarma) and its comparison with preparation LAMISIL CREAM (Novartis) in patients with interdigital form of tinea ...
    Medical condition: tinea pedis var. interdigitale
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-001873-91 Sponsor Protocol Number: XRP6976J/4001 Start Date*: 2005-11-14
    Sponsor Name:Aventis Pharma
    Full Title: Docetaxel (Taxotere) v léčbě hormonálně independentního karcinomu prostaty.
    Medical condition:
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2004-002802-31 Sponsor Protocol Number: PENT-IBD-CH CZ Start Date*: 2005-01-25
    Sponsor Name:Ferring-Leciva, a.s.
    Full Title: Multicentre, Controlled, Randomised, Open, Cross-over Study Comparing the Acceptability of Pentasa® Sachets versus Pentasa® tbl. 500mg in Children with Crohn´s Disease
    Medical condition: children patients with the Crohn s disease in any stage (where mesalazine treatment is appropriate)
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 11 07:07:02 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA